The outcome of IHE initiatives is providing better information for developing health policy and best medical practices. IHE disseminates information in many ways. In addition to publications in peer-reviewed journals, IHE produces books and a variety of reports synthesizing information in a particular field.
If you cannot find the publication or report you are seeking, please contact us at [email protected]. Thank you!
Refine your search by clicking filters to the left.
The Institute for Health Economics (IHE) is conducting an invitational, virtual policy roundtable on progressive fibrosing interstitial lung disease (PF-ILD) on November 20th, 2020. This policy roundtable will seek to gain multi-stakeholder consensus on policy recommendations intended to optimize care for PF-ILD patients Key areas for discuss are in the following three areas: Multi-disciplinary…
The IHE Life Sciences Commercialization Program supports Alberta, Saskatchewan, Manitoba and British Columbia-based life sciences companies with promising, market-ready healthcare technology that are currently seeking procurement in Canadian or international markets. Support includes the development of an economic model to quantify the technology value…
News items are kept on the IHE website for 6 months. If you require an older news item, please contact us at [email protected].
For media inquiries, please contact John Sproule, Senior Policy Director at [email protected]
The IHE has a dedicated Life Sciences SME Platform within the Institute that collaborates with and provides support for SMEs in the life sciences. The IHE provides services to: educate SMEs and support organizations (e.g., accelerators) on the value and use of health economics to support decisions along the commercialization journey as well as procurement efforts; provide early-stage…
| Sean M. Bagshaw, Dat Tran, Dawn Opgenorth, Xiaoming Wang, Danny Zuege, Armann Ingolfsson, Henry T. Stelfox, Thanh Nguyen
Delay in transfer from intensive care unit (ICU) may contribute to strained capacity. Using a population-based patient cohort in 17 ICUs in Alberta between 2012 and 2016, this paper describes the epidemiologic features and healthcare costs attributable to potentially avoidable delays in ICU discharge. Potentially avoidable discharge delay occurred in approximately 70% of ICU patients…
Summary: We examined the association between optimal control of dyslipidemia and mortality and healthcare costs in patients with high risk for cardiovascular disease (HRCVD) between 2012-2016 in Alberta, Canada. HRCVD patients who were optimally controlled had lower mortality and incurred modestly higher costs, compared to those who were not. Secondary prevention patients with…
23 November 2018 | 30 November 2018 Calgary, Alberta | Edmonton, Alberta 08:30 – 08:45 Introductions and Overview of IHE Mr. Dan PalfreyDownload Presentation 08:45 – 09:30 Case Study One Mr. Dan PalfreyDownload Presentation 09:30 – 10:15 Innovation Adoption in Alberta and Canada Dr. Christopher McCabeDownload Presentation 10:15 – 10:30 Break 10:30 – 11:30 Principles of Health Economics…
| Dat Tran, Robert Welsh, Arto Ohinmaa, Thanh Nguyen, Padma Kaul
Little is known about the resource use and cost burden of acute myocardial infarction (AMI) beyond the index event. We examined resource use and care costs during the first and each subsequent year, among patients with incident AMI.
Summary Report Defining decision-grade real-world evidence and its role in the Canadian context: A design sprint – Summary report of a workshopDownload Summary Report (English) Définir les données probantes du monde réel utiles à la prise de décisions et leur rôle en contexte canadien: Un sprint de conception Rapport sommaire d’un atelier Téléchargez le rapport sommaire d’un atelier…
Health Technology Innovation Platform (HTIP) events are designed to support the HTIP initiative, by collaborating with and providing support for small- and medium-sized enterprises (SMEs) as well as multi-national enterprises (MNEs) in the life sciences. These events support the mission of the HTIP to enhance decision-making efficiency and improve value for money for purchasers…
Speaker Biographies Keynote Speaker Dr. Catherine CalderwoodChief Medical Officer, Scotland Catherine Calderwood has been the Chief Medical Officer for Scotland since 2015. Catherine qualified from Cambridge and Glasgow Universities and continues to work as an obstetrician at a regular antenatal clinic at the Royal Infirmary of Edinburgh. She is responsible for the Health Promoting…
19 September 2018Edmonton, Alberta Welcome and Greetings WelcomeDr. Lorne TyrrellBoard Chair, IHE Greetings from the ProvinceMr. Justin RiemerAssistant Deputy Minister, Innovation and Strategic Operations Division, Alberta Healthhttps://vimeo.com/album/5450281/video/292002619 Keynote Presentations Realistic Medicine – Lessons from ScotlandDr. Catherine CalderwoodChief Medical Officer,…
Institute of Health Economics – Corporate Reports The Institute of Health Economics (IHE) is a not-for-profit organization funded through grants and commissioned work from public and private sector partners. The IHE is committed to transparency and accountability in the work we conduct. Key corporate reports which are completed and in development are outlined below. Strategic Plan:…
How do you engage citizens, decision-makers, and experts in an appropriate way to address complex health issues? One approach is the Consensus Development Conference. The Consensus Development Conference approach has been used effectively in Alberta by the Institute of Health Economics. The program is modelled on the National Institute of Health (NIH) Consensus Development program…
Past Events The IHE serves as a neutral convenor for health policy dialogue and evidence development and dissemination. The format for each event is tailored to suit the topic, purpose, and audience. Events hosted or co-hosted by the IHE include the well-regarded Consensus Development Conference Series, which has seen us host international events on Fetal Alcohol Spectrum Disorder…
IHE Events The IHE serves as a neutral convenor for health policy dialogue and evidence development and dissemination. The format for each event is tailored to suit the topic, purpose, and audience. The IHE hosts various events of different sizes and audiences, on a wide variety of topics. Past events have included Health Policy events, the IHE Innovation Forum series, Roundtables,…
| S.P. Bisch, T. Wells, L. Gramlich, P. Faris, X. Wang, Dat Tran, Thanh Nguyen, S. Glaze, P. Chu, P. Ghatage, J. Nation, V. Capstick, H. Steed, J. Sabourin, G. Nelson
The Institute of Health Economics has contributed to a study published in the Journal Gynecologic Oncology. The study described the effects of Enhanced Recovery After Surgery (ERAS) guideline implementation in gynecologic oncology on length of stay, patient outcomes, and economic impact in Alberta. The study compared pre-and post-guideline implementation outcomes at two centers…
In addition to clinical data to demonstrate the safety and efficacy of a technology, life sciences small- and medium-sized enterprises (SMEs) require health economic data and analysis to demonstrate the cost-effectiveness of that technology for health systems, creating a comprehensive picture of how the technology is good value for money. Without this key component in an evidentiary…
Health Technology Innovation Platform HTIP is a public-private partnership between Health Canada, Canadian Agency for Drugs and Technologies in Health (CADTH), provincial drug plans (AB, BC, ON) and the innovative pharmaceutical industry including, Boehringer Ingelheim, GlaxoSmithKline, Roche Canada, Takeda Canada, and Novartis Pharmaceuticals Canada Inc. The HTIP goals include…
The goal of the Alberta Secondary Use Data Access (SUDA) initiative is to accelerate health research, support innovation, and strengthen the health system through insights from analysis of health data. The IHE is serving as a partner to the Government of Alberta (GOA) to strengthen analytic capacity and foster collaboration between the GOA, industry, and other contributors. The…
This clinical practice guideline and background document were produced as part of the Prairie Collaborative Immune Globulin (IG) Utilization Management Framework project, which was initiated to establish criteria for IG therapy as a means to increase accountability for the quality, safety, and sustainability of the blood supply system, and to demonstrate stewardship for the use…
Community Voices: Diabetes in Indigenous Populations is a video project that aims to highlight Indigenous perspectives on health, and promote shared learning for a variety of stakeholders within the context of health, well-being, and health care in Canada. New videos from the series will be added regularly, and will highlight voices from Indigenous communities describing current…
| Jasmine Brown, Roger Bland, Egon Jonsson, Andrew Greenshaw
Objective: Fetal alcohol spectrum disorder (FASD) is a medical term used to describe a range of mental and physical disabilities caused by maternal alcohol consumption. The role of alcohol as a teratogen and its effects on the cellular growth of the embryo and the fetus were not determined on scientific grounds until the late 1960s. However, the link between alcohol use during…
| Jasmine Brown, Roger Bland, Egon Jonsson, Andrew Greenshaw
Objective: Fetal Alcohol Spectrum Disorder (FASD) is a preventable disorder caused by maternal alcohol consumption and marked by a range of physical and mental disabilities. Although recognized by the scientific and medical community as a clinical disorder, no internationally standardized diagnostic tool yet exists for FASD. Methods and Results: This review seeks to analyse the…
| Charles Yan, Yufei Zheng, Michael D. Hill, Balraj Mann, Thomas Jeerakathil, Noreen Kamal, Shy Amlani, Anderson Chuck
Abstract: We present a conceptual approach to determine the optimal solution to delivering a health technology, consistent with the objective of maximizing patient outcomes subject to resources available to a publicly funded health system. The article addresses two key policy questions: 1) adding system values through appropriate planning of health services delivery and 2) considering…
Program
Doing the Right Thing ... Right: Evidence Informing Clinical Decision-Making Forum – Final ProgramDownload Final Program
Selected References
Dr. Holroyd's Selected References – Low Value Care / Cognitive BiasesDownload Selected References
Thursday, 22 February 2018Edmonton, Alberta 13:00 – 13:15 Welcome from the IHE Dr. Chris McCabeCEO, Institute of Health Economicshttps://vimeo.com/album/5021382/video/258736790 Greetings from the Province of Alberta Mr. Justin RiemerADM, Innovation & Strategic Operations, Alberta Healthhttps://vimeo.com/album/5021382/video/257997522 13:15 – 14:35 Where Does the…
Speaker Biograpies Keynote Speakers Dr. Brian O’Rourke Dr. Brian O’Rourke is the President and Chief Executive Officer of CADTH. He joined CADTH in January of 2009 following a distinguished career as a Pharmacist and Health Service Executive with the Canadian military. With over 30 years of experience in health care, Brian actively positions CADTH as the leading source…
Objective: The aim of this study was to analyze the health care costs and savings associated with quality improvement (QI) interventions initiated and implemented utilizing the National Surgical Quality Improvement Program (NSQIP). Background: Five acute care facilities of Alberta Health Services (AHS) adopted NSQIP in 2015 for a pilot project. Methods: The cost-savings of NSQIP…
To learn more about the Alberta Real World Evidence (RWE) Consortium, please visit www.AlbertaRWE.ca! Evidence that captures the observed impact of a process or technology on health outcomes and resource utilization outside of controlled clinical trials (real-world evidence or RWE) is highly valuable to technology developers, manufacturers, regulators, payers, clinicians, and…